Investors

2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
March 09, 2017
Codexis Reports 2016 Fourth Quarter and Full Year Financial Results
Achieves 2016 total revenues and gross margin guidance, introduces 2017 financial guidance Conference call begins at 4:30 p.m. Eastern time today Accompanying slide presentation available on Investor section of company website REDWOOD CITY, Calif., March 09, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces financial results for the three and 12 months ended December 31, 2016, and provides a business update. “Our solid fourth quarter per... 
March 02, 2017
Codexis to Hold 2016 Fourth Quarter and Full Year Conference Call on March 9
REDWOOD CITY, Calif., March 02, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2016 financial results after market close on Thursday, March 9, 2017. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update. Live Call: U.S. 855 890 8665   ... 
January 06, 2017
Codexis to Offer High-Performance Enzymes for Diagnostics Markets
REDWOOD CITY, Calif., Jan. 06, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will offer high-performance enzymes for customers using next generation sequencing (NGS) and polymerase chain reaction (PCR/qPCR) for in vitro molecular diagnostic applications.  Codexis’ first proprietary enzyme for this market will target improved library preparation for NGS users, and is expected to be available in beta-test format by the second quart... 

Sign up for E-mail Alerts

You may automatically receive Codexis, Inc. information by e-mail




Enter your e-mail address here:
Print Page Print Page | E-mail Page E-mail Page |

Share Page

X
| Financial Tear Sheet Tear Sheet
built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue